中国药房2016，Vol.27Issue(26)：3609-3612,3613,5.DOI:10.6039/j.issn.1001-0408.2016.26.03
我国近5年降脂药药物经济学研究文献分析
Literature Analysis of Pharmacoeconomic Researches about Lipid-lowering Drugs in China in Recent 5 Years
摘要
Abstract
OBJECTIVE:To investigate the situation of pharmacoeconomic researches about lipid-lowering drugs in China, and to seek the regimen with good cost-effectiveness in order to provide reference for rational drug use in the clinic. METHODS:Retrieved from CNKI and Wanfang database,pharmacoeconomic literatures about lipid-lowering drugs,published in domestic jour-nals during 2011-2015,were included to discuss the problems of pharmacoeconomic researches about lipid-lowering drugs and put forward related suggestions. RESULTS:Rosuvastatin and other medicines showed good cost-effectiveness,while there were many problems of domestic published pharmacoeconomic researches about lipid-lowering drugs,such as different research methods,dif-ferent treatment courses,different methods of cost calculation,single effect index and absence of ADR. On the whole,the research-es were low in quality,which led the difficulty of accurately obtaining the drugs with best cost-effectiveness. CONCLUSIONS:In the future,related researches should confirm research duration and health output index,effect index and evaluation method accord-ing to disease types and research objectives;enhance the unity of research and design methods;pay attention to cost discount;in addition,strengthen pharmacoeconomic researches about lipid-lowering TCM and compare it with chemical drugs.关键词
降脂药/药物经济学/文献分析/问题/建议Key words
Lipid-lowering drugs/Pharmacoeconomic/Literature analysis/Problems/Suggestions分类
医药卫生引用本文复制引用
王艳春,吕巧莉,孙建勋,徐若南..我国近5年降脂药药物经济学研究文献分析[J].中国药房,2016,27(26):3609-3612,3613,5.
